Position
CSS LLC/IL in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $5.77M$1.13 → $1.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 26.5M | $29.8M | — | — | — | 1.3% |
| Q1 2026 | 10.1M | $17.1M | $1.70 | $5.77M | −$18.5M | 0.8% |